Business and Finance
PRINCETON, N.J. (Map) -
All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our Recommended List of stocks, which outperformed the S&P 500 by 15% in 2008.
All trial subscribers will also receive our recently published special report "Nine High-Yield Stocks for '09" for free. This 38-page report gives an in-depth examination of nine high-yielding stocks that could help get investors through this difficult market. The report digs into each stock's dividend history, business activities, strengths, weaknesses, latest earnings report, and much more.
Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/pr/?refer=BMR458P
In its daily report, BullMarket.com wrote: "With a new president set to take office in three weeks and that president pledging to spend upwards of
BullMarket.com looked at the following topics, among others:
-- Does Tetra Tech's focus on water infrastructure make it attractive?
-- How will a new logistics support program in Iraqi affect KBR?
-- Why has Aecom been one of the hottest infrastructure stocks recently and can it continue its momentum?
-- Will Fluor and Jacobs Engineering's ties to the oil and gas industry help or hinder the stocks?
--Which infrastructure stocks are BullMarket.com's favorites for 2009?
About BullMarket.com:
Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and
Contact
Indie Research Advisors, LLC
|
|